[
    {
        "masterId": "NCLEX-2026-MISSION-500-19-1771956936025",
        "itemType": "dragAndDropCloze",
        "topic": "Heparin/Warfarin Anticoagulation Safety",
        "category": "Pharmacology",
        "difficulty": 5,
        "stem": "A 72-year-old male patient is admitted to the medical-surgical unit with a diagnosis of deep vein thrombosis (DVT). The patient has a history of atrial fibrillation and is currently on warfarin therapy. The physician orders a heparin drip to be started concurrently, and orders labs. Review the EHR and complete the following statements to ensure patient safety during anticoagulation therapy. Drag from the options below to accurately complete each sentence.",
        "itemContext": {
            "SBAR": "14:00, I am calling about John Smith, a 72-year-old male admitted for DVT. He also has a history of atrial fibrillation and is currently on warfarin. The patient reported leg pain and swelling this morning. His vital signs are stable: BP 130/80 mmHg, HR 88 bpm, RR 18, SpO2 96% on room air. He's alert and oriented. We've started him on oxygen via nasal cannula at 2L/min per protocol. The physician has ordered a heparin drip to be started concurrently with his warfarin. Labs are pending, but his INR this morning was 2.8. I am concerned about the risk of bleeding with the initiation of heparin while he's already on warfarin. Do you want to adjust the heparin dosing or consider bridging therapy differently? He's also complaining of mild back pain. Warfarin was last dose adjusted 3 days ago. Considering current orders, watch for signs of bleeding and monitor labs per orders, including aPTT and platelets. Call back with any concerns.",
            "Labs": "INR: 2.8, Hemoglobin: 11.5 g/dL, Platelets: 140,000/mcL, aPTT: 48 seconds",
            "Vitals": "BP: 130/80 mmHg, HR: 88 bpm, RR: 18, SpO2: 96% on room air, Temperature: 37.0Â°C",
            "MAR": "Warfarin 5mg PO daily",
            "Radiology": "Lower extremity venous doppler ultrasound showing DVT in left calf.",
            "nursingNotes": "Patient reports leg pain 6/10. Complains of mild back pain."
        },
        "options": [
            "Vitamin K",
            "Protamine sulfate",
            "Heparin",
            "Warfarin",
            "PT/INR",
            "aPTT",
            "LMWH",
            "increased",
            "decreased",
            "consistent",
            "bleeding",
            "thrombosis",
            "2.0-3.0",
            "2.5-3.5"
        ],
        "correctResponses": [
            "aPTT",
            "bleeding",
            "decreased",
            "2.0-3.0",
            "Vitamin K"
        ],
        "rationale": "Concurrent administration of heparin and warfarin increases the risk of bleeding due to their synergistic anticoagulant effects. Monitoring the aPTT is crucial for heparin, while PT/INR is for warfarin, though the INR is already elevated due to warfarin. A decreasing platelet count may indicate heparin-induced thrombocytopenia (HIT), requiring immediate intervention. The therapeutic INR range for atrial fibrillation and DVT is typically 2.0-3.0. An INR above this range further elevates bleeding risk. Vitamin K is the antidote for warfarin, and would be indicated for an INR above therapeutic range, in the presence of bleeding, or if emergent surgery is needed. Protamine sulfate is the antidote for heparin.",
        "scoringRules": {
            "overall": "0/1"
        },
        "feedback": {
            "correct": "The patient's anticoagulation is being closely monitored to prevent complications.",
            "incorrect": "Review the patient's lab values and medications to ensure safe administration of anticoagulants."
        },
        "clinicalPearls": "When initiating heparin therapy in a patient already on warfarin, closely monitor coagulation studies and assess for signs of bleeding. Overlap therapy is common but requires careful monitoring and potential dose adjustments. Be vigilant for signs and symptoms of heparin-induced thrombocytopenia (HIT).",
        "questionTrap": "Many students focus solely on the DVT without recognizing the additive bleeding risk of concurrent heparin and warfarin. Students may incorrectly focus on the aPTT as the sole monitoring parameter, failing to recognize the importance of INR and platelet monitoring. Students may forget Vitamin K is the antidote for warfarin.",
        "mnemonic": "When using Heparin and Warfarin together, think 'Double Trouble' for bleeding risk; monitor aPTT for Heparin, PT/INR for Warfarin.",
        "clozeStatements": [
            "When administering heparin, it is essential to monitor the [aPTT] to ensure therapeutic anticoagulation.",
            "The concurrent use of heparin and warfarin significantly increases the risk of [bleeding].",
            "Starting heparin on a patient already on warfarin may cause a [decreased] platelet count.",
            "The target INR range for a patient on warfarin with atrial fibrillation and DVT is typically [2.0-3.0].",
            "If the patient's INR is critically high, the medication that the nurse should prepare to administer is [Vitamin K]."
        ]
    }
]